Acting Deputy Director, Laboratory Head
Walter and Eliza Hall Institute
Parkville, Victoria, Australia
Sant-Rayn Pasricha is a haematologist, epidemiologist and molecular biologist who leads a research program addressing anaemia control in the global health context. He is a Division Head at the Walter and Eliza Hall Institute of Medical Research and consultant physician at the Royal Melbourne Hospital. He presently leads a series of field trials exploring solutions for anaemia control in south Asia and sub-Saharan Africa, as well as a basic science research program seeking to make fundamental discoveries around biology. He also leads the WHO Collaborating Centre for Anaemia Detection and Control. He has published as first/ senior author in journals including the New England Journal of Medicine, Lancet, Lancet Global Health, BMJ, Science Translational Medicine, and Blood.
Late Breaking/Rapid Science Oral Session
Tuesday, July 2, 2024
8:00 AM – 9:30 AM CT
Disclosure(s): CSL-Vifor: Advisory Committee/Board Member (Ongoing)
ITL Biomedical: Consultant (Ongoing)
Silence Therapeutics: Royalties or Patent Beneficiary (Ongoing)
World Health Organization: Advisory Committee/Board Member (Ongoing); Consultant (Ongoing); Grant/Research Support (Ongoing)
Tuesday, July 2, 2024
8:00 AM – 8:12 AM CT
Disclosure(s): CSL-Vifor: Advisory Committee/Board Member (Ongoing)
ITL Biomedical: Consultant (Ongoing)
Silence Therapeutics: Royalties or Patent Beneficiary (Ongoing)
World Health Organization: Advisory Committee/Board Member (Ongoing); Consultant (Ongoing); Grant/Research Support (Ongoing)
Emerging Innovations in Anemia Epidemiology, Measurement, and Interventions
Tuesday, July 2, 2024
8:00 AM – 9:30 AM CT
Disclosure(s): CSL-Vifor: Advisory Committee/Board Member (Ongoing)
ITL Biomedical: Consultant (Ongoing)
Silence Therapeutics: Royalties or Patent Beneficiary (Ongoing)
World Health Organization: Advisory Committee/Board Member (Ongoing); Consultant (Ongoing); Grant/Research Support (Ongoing)
Novel Interventions to Improve Anemia in Pregnant Women and Children
Tuesday, July 2, 2024
8:44 AM – 8:57 AM CT
Disclosure(s): CSL-Vifor: Advisory Committee/Board Member (Ongoing)
ITL Biomedical: Consultant (Ongoing)
Silence Therapeutics: Royalties or Patent Beneficiary (Ongoing)
World Health Organization: Advisory Committee/Board Member (Ongoing); Consultant (Ongoing); Grant/Research Support (Ongoing)
Panel Discussion - Emerging Innovations in Anemia Epidemiology, Measurement, and Interventions
Tuesday, July 2, 2024
9:10 AM – 9:30 AM CT
Disclosure(s): CSL-Vifor: Advisory Committee/Board Member (Ongoing)
ITL Biomedical: Consultant (Ongoing)
Silence Therapeutics: Royalties or Patent Beneficiary (Ongoing)
World Health Organization: Advisory Committee/Board Member (Ongoing); Consultant (Ongoing); Grant/Research Support (Ongoing)